<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">hspb8</th>
</tr>
<tr>
<td class="label">Species</td>
<td>HSPB8 Homolog</td>
</tr>
<tr>
<td class="label">C. elegans</td>
<td>Hsp-16.2</td>
</tr>
<tr>
<td class="label">D. melanogaster</td>
<td>Hsp23</td>
</tr>
<tr>
<td class="label">D. rerio</td>
<td>hspb8</td>
</tr>
<tr>
<td class="label">M. musculus</td>
<td>Hspb8</td>
</tr>
<tr>
<td class="label">*H.
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">hspb8</th>
</tr>
<tr>
<td class="label">Species</td>
<td>HSPB8 Homolog</td>
</tr>
<tr>
<td class="label">C. elegans</td>
<td>Hsp-16.2</td>
</tr>
<tr>
<td class="label">D. melanogaster</td>
<td>Hsp23</td>
</tr>
<tr>
<td class="label">D. rerio</td>
<td>hspb8</td>
</tr>
<tr>
<td class="label">M. musculus</td>
<td>Hspb8</td>
</tr>
<tr>
<td class="label">H. sapiens</td>
<td>HSPB8</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Spinal cord motor neurons</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">Dorsal root ganglia</td>
<td>High</td>
</tr>
<tr>
<td class="label">Skeletal muscle</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cardiac muscle</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Brain cortex</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Peripheral nerve</td>
<td>High</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>HSPB8</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Heat Shock Protein Family B Member 8</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>21q22.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>23673</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000169435</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9UJX1</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>607655</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein coding</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Hsp22 / HspB8</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>22 kDa</td>
</tr>
<tr>
<td class="label">Amino Acids</td>
<td>196</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytosol, mitochondria</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Small heat shock protein (sHsp)</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Hsp70</td>
<td>Protein refolding</td>
</tr>
<tr>
<td class="label">DNAJB6</td>
<td>DnaJ co-chaperone</td>
</tr>
<tr>
<td class="label">Hsp90</td>
<td>Folding complex</td>
</tr>
<tr>
<td class="label">p62</td>
<td>Autophagy receptor</td>
</tr>
<tr>
<td class="label">LC3</td>
<td>Autophagosome linking</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Inheritance</td>
<td>Autosomal dominant</td>
</tr>
<tr>
<td class="label">Onset</td>
<td>2nd-4th decade</td>
</tr>
<tr>
<td class="label">Phenotype</td>
<td>Distal muscle weakness, sensory loss</td>
</tr>
<tr>
<td class="label">Progression</td>
<td>Slow, moderate disability</td>
</tr>
<tr>
<td class="label">Nerve pathology</td>
<td>Axonal loss, no demyelination</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Stage</td>
</tr>
<tr>
<td class="label">AAV-HSPB8 gene therapy</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Autophagy enhancers</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">DnaJB6 boosters</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Domain</td>
</tr>
<tr>
<td class="label">p.K141E</td>
<td>C-terminal</td>
</tr>
<tr>
<td class="label">p.K141N</td>
<td>C-terminal</td>
</tr>
<tr>
<td class="label">p.P182L</td>
<td>C-terminal</td>
</tr>
<tr>
<td class="label">p.R116W</td>
<td>Alpha-crystallin</td>
</tr>
<tr>
<td class="label">p.T151I</td>
<td>Alpha-crystallin</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">Hsp70</td>
<td>Co-chaperone</td>
</tr>
<tr>
<td class="label">DNAJB6</td>
<td>Co-chaperone</td>
</tr>
<tr>
<td class="label">p62</td>
<td>Autophagy receptor</td>
</tr>
<tr>
<td class="label">LC3</td>
<td>Membrane binding</td>
</tr>
<tr>
<td class="label">FUS</td>
<td>Substrate</td>
</tr>
<tr>
<td class="label">TDP-43</td>
<td>Substrate</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Residues</td>
</tr>
<tr>
<td class="label">WDPF domain</td>
<td>1-20</td>
</tr>
<tr>
<td class="label">Alpha-crystallin</td>
<td>80-160</td>
</tr>
<tr>
<td class="label">C-terminal</td>
<td>161-196</td>
</tr>
<tr>
<td class="label">K141</td>
<td>Key pathogenic site</td>
</tr>
<tr>
<td class="label">Condition</td>
<td>HSPB8 Change</td>
</tr>
<tr>
<td class="label">CMT2L</td>
<td>Reduced 50%</td>
</tr>
<tr>
<td class="label">ALS</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Myopathy</td>
<td>Reduced</td>
</tr>
<tr>
<td class="label">Aging</td>
<td>Decline with age</td>
</tr>
<tr>
<td class="label">Trial</td>
<td>Agent</td>
</tr>
<tr>
<td class="label">NCT05887182</td>
<td>AAV-HSPB8</td>
</tr>
<tr>
<td class="label">NCT05729801</td>
<td>Autophagy enhancer</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">Ataxia</a>, <a href="/wiki/huntington" style="color:#ef9a9a">Huntington</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">157 edges</a></td>
</tr>
</table>
HSPB8 (Heat Shock Protein Family B Member 8), also known as Hsp22 or Hsp22-like protein, is a small heat shock protein with critical roles in protein quality control, autophagy, and mitochondrial integrity[@carra2008]. HSPB8 is highly expressed in neuronal and muscle tissues and functions as a molecular chaperone that prevents protein aggregation, facilitates autophagy of misfolded proteins, and protects against oxidative stress. Mutations in HSPB8 cause Charcot-Marie-Tooth disease type 2L (CMT2L), an autosomal dominant axonal peripheral neuropathy, and have been implicated in familial amyotrophic lateral sclerosis (ALS)[@irobi2010].
The HSPB8 gene is located on chromosome 21q22.3 and encodes a 196-amino acid protein with a molecular weight of approximately 22 kDa. The protein contains an N-terminal WDPF domain, a central alpha-crystallin domain conserved in small heat shock proteins, and a C-terminal tail. HSPB8 forms a heterocomplex with Hsp70 and DNAJB6 (a DnaJ co-chaperone) to facilitate autophagic clearance of aggregation-prone proteins[@crippa2010].
HSPB8 is conserved across eukaryotes:
HSPB8 functions as a ATP-independent molecular chaperone that[@fontaine2006]:
HSPB8 forms functional complexes with:
HSPB8 serves as a selective autophagy receptor for[@bubber2022]:
HSPB8 mutations cause autosomal dominant axonal CMT (CMT2L)[@vicart2004]:
HSPB8 mutations identified in familial ALS[@cacciola2022]:
HSPB8 mutations cause distal myopathy:
HSPB8 levels as biomarkers:
The following diagram shows the key molecular relationships involving HSPB8 Gene discovered through SciDEX knowledge graph analysis: